Blog
Latest Insights & Industry Reports
Stay informed with our latest analysis, market insights, and thought leadership content from the Intertwine team.
Posts
October 2, 20264 min read
Twine Saver, Q3 2026: the quarter in company building
Fewer but larger life science deals, contingent pay in nearly every one of them, a selective IPO window, a Federal Reserve that turned to tightening, and business formation that peaked in July. A look back at July through September 2026.
Intertwine Partners
Twine SaverQuarterly reviewMarkets
Read More
October 2, 20264 min read
Twine Saver, Q3 2026: business formation and corporate strategy
New business applications peaked in July and cooled in August. Companies reshaped themselves through carve-outs, roll-ups, reverse mergers and acquisitions of AI and data businesses, while the cost of capital rose.
Intertwine Partners
Twine SaverQuarterly reviewStrategy
Read MoreOctober 2, 20265 min read
Twine Saver, Q3 2026: life science deals and public markets
The quarter's acquisitions, licences and IPOs in biotech, pharma, medtech and contract manufacturing, and the deal structures that ran through them: contingent value rights, asset-only purchases and strategic investors in IPOs.
Intertwine Partners
Twine SaverQuarterly reviewLife sciencesMarkets
Read More
July 10, 20253 min read
Launch announcement: Twine Time
Our identity, in motion. The INTERTWINE wordmark, the marks of our three companies and the one thread that joins them, built from the start to be clear and to work hard.
Intertwine Team
LaunchAnnouncementPortfolioOperational excellence
Read More
July 1, 20254 min read
Ready. Set. Efficient. Intertwine is officially here.
Intertwine launches as the parent of three independently operated companies in consulting, scientific commercialization and scientific software, joined by one commitment to operational efficiency.
Intertwine Team
LaunchAnnouncementPortfolioOperational excellence
Read More